Skip to main content
Year archive

AstraZeneca PLC — 2020 filings

All 307 regulatory filings released by AstraZeneca PLC (AZN) in 2020, sourced directly from the official regulator.

307 Filings
2020 Period
2020 filings (307)
Filing Released Lang
ASTRAZENECA'S COVID-19 VACCINE AUTHORISED IN UK
Regulatory Filings
2020-12-30 English
AstraZeneca’s COVID-19 vaccine authorised in UK
Regulatory Filings
2020-12-30 English
LYNPARZA APPROVED IN JAPAN FOR THE TREATMENT OF ADVANCED OVARIAN, PROSTATE AND P
Regulatory Filings
2020-12-29 English
Lynparza approved in Japan for three cancers
Regulatory Filings
2020-12-29 English
TAGRISSO APPROVED IN THE US FOR THE ADJUVANT TREATMENT OF PATIENTS WITH EARLY-ST
Regulatory Filings
2020-12-21 English
UPDATE ON US REGULATORY REVIEW OF ROXADUSTAT IN ANAEMIA OF CHRONIC KIDNEY DISEAS
Regulatory Filings
2020-12-21 English
Tagrisso approved in the US for early lung cancer
Regulatory Filings
2020-12-21 English
Update on US regulatory review of roxadustat
Regulatory Filings
2020-12-21 English
425 Filing
Regulatory Filings
2020-12-18 English
DIRECTOR/PDMR SHAREHOLDING
Regulatory Filings
2020-12-17 English
Director/PDMR Shareholding
Director's Dealing
2020-12-17 English
425 Filing
Regulatory Filings
2020-12-17 English
DIRECTOR/PDMR SHAREHOLDING
Regulatory Filings
2020-12-16 English
Director/PDMR Shareholding
Director's Dealing
2020-12-16 English
IMFINZI NEW DOSE RECEIVES POSITIVE EU CHMP OPINION
Regulatory Filings
2020-12-15 English
Imfinzi new dose receives positive EU CHMP opinion
Legal Proceedings Report
2020-12-15 English
425 Filing
Regulatory Filings
2020-12-15 English
TRASTUZUMAB DERUXTECAN POSITIVE CHMP
Regulatory Filings
2020-12-14 English
TRIXEO AEROSPHERE APPROVED IN THE EU FOR COPD
Regulatory Filings
2020-12-14 English
ASTRAZENECA TO ACQUIRE ALEXION PHARMACEUTICALS INC
Regulatory Filings
2020-12-14 English
Trastuzumab deruxtecan positive CHMP
Regulatory Filings
2020-12-14 English
Trixeo Aerosphere approved in the EU for COPD
Regulatory Filings
2020-12-14 English
AstraZeneca to acquire Alexion Pharmaceuticals Inc
M&A Activity
2020-12-14 English
425 Filing
Regulatory Filings
2020-12-14 English
425 Filing
Regulatory Filings
2020-12-14 English
425 Filing
Regulatory Filings
2020-12-14 English
425 Filing
Regulatory Filings
2020-12-14 English
BLOCK LISTING INTERIM REVIEW
Regulatory Filings
2020-12-01 English
TOTAL VOTING RIGHTS
Regulatory Filings
2020-12-01 English
Total Voting Rights
Regulatory Filings
2020-12-01 English
Block listing Interim Review
Share Issue/Capital Change
2020-12-01 English
CRESTOR TO BE DIVESTED TO GRUNENTHAL IN EUROPE
Regulatory Filings
2020-12-01 English
Crestor to be divested to Grünenthal in Europe
M&A Activity
2020-12-01 English
FORXIGA APPROVED IN JAPAN FOR CHRONIC HEART FAILURE
Regulatory Filings
2020-11-30 English
Forxiga approved in Japan for heart failure
Regulatory Filings
2020-11-30 English
AZD1222 VACCINE EFFECTIVE AGAINST COVID-19
Regulatory Filings
2020-11-23 English
AZD1222 vaccine effective against COVID-19
Regulatory Filings
2020-11-23 English
IMFINZI NEW DOSING APPROVED IN THE US
Regulatory Filings
2020-11-20 English
Imfinzi new dosing approved in the US
Regulatory Filings
2020-11-20 English
Delisting Announcement 2020
Delisting Announcement
2020-11-13 English
TEZEPELUMAB PHASE III TRIAL MET PRIMARY ENDPOINT
Regulatory Filings
2020-11-10 English
Tezepelumab Phase III trial met primary endpoint
Regulatory Filings
2020-11-10 English
CALQUENCE APPROVED IN THE EU FOR CLL
Regulatory Filings
2020-11-09 English
Calquence approved in the EU for CLL
Regulatory Filings
2020-11-09 English
BRILINTA APPROVED IN THE US IN STROKE
Regulatory Filings
2020-11-06 English
Brilinta approved in the US in stroke
Regulatory Filings
2020-11-06 English
AZN: YEAR-TO-DATE AND Q3 2020 RESULTS
Regulatory Filings
2020-11-05 English
FORXIGA APPROVED IN THE EU FOR HEART FAILURE
Regulatory Filings
2020-11-05 English
LYNPARZA APPROVED IN THE EU AS 1ST-LINE MAINTENANCE TREATMENT WITH BEVACIZUMAB F
Regulatory Filings
2020-11-05 English
LYNPARZAAPPROVED IN THE EU FOR THE TREATMENT OF BRCA- MUTATED METASTATIC CASTRAT
Regulatory Filings
2020-11-05 English
Lynparza approved in the EU for wider ovarian use
Regulatory Filings
2020-11-05 English
Lynparza approved in the EU for prostate cancer
Legal Proceedings Report
2020-11-05 English
Forxiga approved in the EU for heart failure
Regulatory Filings
2020-11-05 English
AZN: Year-to-date and Q3 2020 results
Earnings Release 9M 2020
2020-11-05 English
Regulatory Filings 2020
Regulatory Filings
2020-11-03 English
TOTAL VOTING RIGHTS
Regulatory Filings
2020-11-02 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2020-11-02 English
ATACAND TO BE DIVESTED TO CHEPLAPHARM IN MORE THAN 70 COUNTRIES
Regulatory Filings
2020-10-30 English
Atacand to be divested in more than 70 countries
Regulatory Filings
2020-10-30 English
DIRECTORATE CHANGE
Regulatory Filings
2020-10-29 English
Directorate Change
Board/Management Information
2020-10-29 English
ENHERTU GRANTED PRIORITY REVIEW IN THE US FOR THE TREATMENT OF HER2-POSITIVE MET
Regulatory Filings
2020-10-28 English
FORXIGA CARDIOVASCULAR OUTCOMES BENEFIT APPROVED IN CHINA
Regulatory Filings
2020-10-28 English
Enhertu US Priority Review in gastric cancer
Regulatory Filings
2020-10-28 English
Forxiga CV outcomes benefit approved in China
Regulatory Filings
2020-10-28 English
TAGRISSO ADJUVANT LUNG CANCER US PRIORITY REVIEW
Regulatory Filings
2020-10-20 English
Tagrisso adjuvant lung cancer US Priority Review
Regulatory Filings
2020-10-20 English
FORXIGA HF RECEIVES POSITIVE CHMP OPINION
Regulatory Filings
2020-10-19 English
TRIXEO AEROSPHERE RECEIVES POSITIVE CHMP OPINION
Regulatory Filings
2020-10-19 English
Forxiga HF receives positive CHMP opinion
Regulatory Filings
2020-10-19 English
Trixeo Aerosphere receives positive CHMP opinion
Regulatory Filings
2020-10-19 English
COVID-19 ANTIBODIES ADVANCE AND GET US FUNDING
Regulatory Filings
2020-10-13 English
COVID-19 antibodies advance and get US funding
Regulatory Filings
2020-10-12 English
FARXIGA GRANTED US BTD IN CHRONIC KIDNEY DISEASE
Regulatory Filings
2020-10-02 English
Farxiga granted US BTD in chronic kidney disease
Regulatory Filings
2020-10-02 English
TOTAL VOTING RIGHTS
Regulatory Filings
2020-10-01 English
Total Voting Rights
Regulatory Filings
2020-10-01 English
DIRECTORATE CHANGE
Regulatory Filings
2020-09-25 English
Directorate Change
Board/Management Information
2020-09-25 English
Regulatory Filings 2020
Regulatory Filings
2020-09-24 English
8-A12B
Regulatory Filings
2020-09-24 English
25
Delisting Announcement
2020-09-24 English
LYNPARZA RECOMMENDED FOR APPROVAL IN THE EU BY CHMP FOR BRCA-MUTATED METASTATIC
Regulatory Filings
2020-09-21 English
LYNPARZARECOMMENDED FOR APPROVAL IN EU BY CHMP AS 1ST-LINE MAINTENANCE TREATMENT
Regulatory Filings
2020-09-21 English
TAGRISSO REDUCED THE RISK OF DISEASE RECURRENCE IN THE BRAIN BY 82% IN THE ADJUV
Regulatory Filings
2020-09-21 English
Lynparza EU recommendation in prostate cancer
Regulatory Filings
2020-09-21 English
Lynparza EU recommendation in ovarian cancer
Regulatory Filings
2020-09-21 English
Tagrisso reduced early lung cancer brain recurrenc
Regulatory Filings
2020-09-21 English
ASTRAZENECA TO LIST US ADR EQUITY AND ALL US DEBT SECURITIES ON NASDAQ
Regulatory Filings
2020-09-10 English
FASENRA MET BOTH CO-PRIMARY ENDPOINTS OF REDUCED NASAL POLYP SIZE AND BLOCKAGE I
Regulatory Filings
2020-09-10 English
AstraZeneca to list all US securities on Nasdaq
Regulatory Filings
2020-09-10 English
Fasenra PhIII OSTRO trial met co-primary endpoints
Regulatory Filings
2020-09-10 English
TOTAL VOTING RIGHTS
Regulatory Filings
2020-09-01 English
Total Voting Rights
Regulatory Filings
2020-09-01 English
IMFINZI APPROVED IN EU FOR SMALL CELL LUNG CANCER
Regulatory Filings
2020-09-01 English
FARXIGA REDUCES CKD PROGRESSION AND RISK OF DEATH
Regulatory Filings
2020-09-01 English
Imfinzi approved in EU for small cell lung cancer
Regulatory Filings
2020-09-01 English
Farxiga reduces CKD progression and risk of death
Regulatory Filings
2020-09-01 English
PHASE I CLINICAL TRIAL INITIATED FOR MONOCLONAL ANTIBODY COMBINATION FOR THE PRE
Regulatory Filings
2020-08-25 English
Ph I trial begins for COVID-19 monoclonal antibody
Legal Proceedings Report
2020-08-25 English
IMFINZI APPROVED IN JAPAN FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG C
Regulatory Filings
2020-08-21 English
Imfinzi approved in Japan for SCLC
Regulatory Filings
2020-08-21 English
IMFINZI GRANTED FDA PRIORITY REVIEW FOR LESS-FREQUENT, FIXED-DOSE USE
Regulatory Filings
2020-08-18 English
Imfinzi US Priority Review; four-week, fixed dose
Regulatory Filings
2020-08-18 English
NYSE CERTIFICATION
Regulatory Filings
2020-08-12 English
FORM 8-A12B
Regulatory Filings
2020-08-06 English
FORM 6-K
Regulatory Filings
2020-08-06 English
FORM 424B2
Regulatory Filings
2020-08-05 English
ASTRAZENECA PRICES A $3BN BOND ISSUE
Regulatory Filings
2020-08-04 English
AstraZeneca prices a $3bn bond issue
Capital/Financing Update
2020-08-04 English
FORM FWP
Regulatory Filings
2020-08-04 English
S-8
Regulatory Filings
2020-08-03 English
TOTAL VOTING RIGHTS
Regulatory Filings
2020-08-03 English
Total Voting Rights
Regulatory Filings
2020-08-03 English
FORM FWP
Regulatory Filings
2020-08-03 English
FORM 424B2
Regulatory Filings
2020-08-03 English
6-K/A
Regulatory Filings
2020-07-31 English
AZN: H1 2020 RESULTS
Regulatory Filings
2020-07-30 English
TAGRISSO US BTD FOR EGFRM ADJUVANT LUNG CANCER
Regulatory Filings
2020-07-30 English
Tagrisso US BTD for EGFRm adjuvant lung cancer
Regulatory Filings
2020-07-30 English
AZN: H1 2020 results
Earnings Release H1 2020
2020-07-30 English
BOARD COMMITTEE CHANGES
Regulatory Filings
2020-07-29 English
Board Committee Changes
Board/Management Information
2020-07-29 English
FARXIGA DAPA-CKD TRIAL MET ALL ENDPOINTS
Regulatory Filings
2020-07-28 English
Farxiga DAPA-CKD trial met all endpoints
Regulatory Filings
2020-07-28 English
IMFINZI RECOMMENDED FOR EU APPROVAL IN SCLC
Regulatory Filings
2020-07-27 English
CALQUENCE RECEIVES POSITIVE CHMP OPINION FOR CLL
Regulatory Filings
2020-07-27 English
ASTRAZENECA ENTERS COLLABORATION IN ONCOLOGY
Regulatory Filings
2020-07-27 English
Calquence receives positive CHMP opinion for CLL
Regulatory Filings
2020-07-27 English
Imfinzi recommended for EU approval in SCLC
Regulatory Filings
2020-07-27 English
AstraZeneca enters collaboration in oncology
M&A Activity
2020-07-27 English
BREZTRI AEROSPHERE APPROVED IN THE US FOR THE MAINTENANCE TREATMENT OF COPD
Regulatory Filings
2020-07-24 English
Breztri Aerosphere approved in the US for COPD
Regulatory Filings
2020-07-24 English
HOLDING(S) IN COMPANY
Regulatory Filings
2020-07-22 English
HOLDING(S) IN COMPANY
Regulatory Filings
2020-07-22 English
Holding(s) in Company
Major Shareholding Notification
2020-07-22 English
HOLDING(S) IN COMPANY
Regulatory Filings
2020-07-21 English
HOLDING(S) IN COMPANY
Regulatory Filings
2020-07-21 English
Holding(s) in Company
Major Shareholding Notification
2020-07-21 English
COVID-19 VACCINE AZD1222 SHOWED ROBUST IMMUNE RESPONSES IN ALL PARTICIPANTS IN P
Regulatory Filings
2020-07-20 English
COVID-19 vaccine Phase I/II showed immune response
Regulatory Filings
2020-07-20 English
DIRECTOR DECLARATION
Regulatory Filings
2020-07-16 English
Director Declaration
Board/Management Information
2020-07-16 English
BRILINTA GRANTED US FDA PRIORITY REVIEW FOR STROKE
Regulatory Filings
2020-07-09 English
Brilinta granted US FDA Priority Review for stroke
Regulatory Filings
2020-07-09 English
LYNPARZA APPROVED IN THE EU FOR BRCA- MUTATED METASTATIC PANCREATIC CANCER
Regulatory Filings
2020-07-08 English
Lynparza approved in the EU for pancreatic cancer
Earnings Release Q3 2020
2020-07-08 English
TOTAL VOTING RIGHTS
Regulatory Filings
2020-07-01 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2020-07-01 English
DIRECTOR/PDMR SHAREHOLDING
Regulatory Filings
2020-06-30 English
Director/PDMR Shareholding
Director's Dealing
2020-06-30 English
SELUMETINIB GRANTED ORPHAN DRUG DESIGNATION IN JAPAN FOR NEUROFIBROMATOSIS TYPE
Regulatory Filings
2020-06-30 English
Selumetinib granted Japan orphan drug designation
Regulatory Filings
2020-06-30 English
HOLDING(S) IN COMPANY
Regulatory Filings
2020-06-17 English
HOLDING(S) IN COMPANY
Regulatory Filings
2020-06-17 English
Holding(s) in Company
Major Shareholding Notification
2020-06-17 English
Holding(s) in Company
Major Shareholding Notification
2020-06-17 English
ASTRAZENECA TO SUPPLY EUROPE WITH UP TO 400 MILLION DOSES OF OXFORD UNIVERSITY'S
Regulatory Filings
2020-06-15 English
Agreement to Supply Europe with COVID-19 Vaccine
Legal Proceedings Report
2020-06-15 English
AstraZeneca PLC - Base prospectus (debt)
Capital/Financing Update
2020-06-11 English
EMTN PROGRAMME ROUTINE TECHNICAL UPDATE: PUBLICATION OF PROSPECTUS
Regulatory Filings
2020-06-11 English
EMTN Programme Routine Technical Update
Regulatory Filings
2020-06-11 English
EMTN Programme Routine Technical Update: Publication of a Prospectus
Capital/Financing Update
2020-06-11 English
Group of companies' accounts made up to 2019-12-31
Regulatory Filings
2020-06-11 English
TOTAL VOTING RIGHTS
Regulatory Filings
2020-06-01 English
BLOCK LISTING INTERIM REVIEW
Regulatory Filings
2020-06-01 English
Block listing Interim Review
Regulatory Filings
2020-06-01 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2020-06-01 English
LYNPARZA RECOMMENDED FOR APPROVAL IN EU BY CHMP FOR BRCA-MUTATED METASTATIC PANC
Regulatory Filings
2020-06-01 English
BRILINTA APPROVED IN THE US TO REDUCE THE RISK OF A FIRST HEART ATTACK OR STROKE
Regulatory Filings
2020-06-01 English
Brilinta obtains additional US approval
Regulatory Filings
2020-06-01 English
Lynparza EU CHMP opinion in pancreatic cancer
Regulatory Filings
2020-06-01 English
Second Price Monitoring Extn
Regulatory Filings
2020-05-29 English
Price Monitoring Extension
Regulatory Filings
2020-05-29 English
ENHERTUSIGNIFICANTLY IMPROVED TUMOUR RESPONSE RATE AND OVERALL SURVIVAL IN HER2-
Regulatory Filings
2020-05-29 English
IMFINZI SHOWED A SUSTAINED OVERALL SURVIVAL BENEFIT IN 1ST-LINE EXTENSIVE-STAGE
Regulatory Filings
2020-05-29 English
Enhertu DESTINY-Gastric01 results from ASCO 2020
Regulatory Filings
2020-05-29 English
Imfinzi sustained overall survival in CASPIAN
Regulatory Filings
2020-05-29 English
TAGRISSO DEMONSTRATED UNPRECEDENTED DISEASE-FREE SURVIVAL IN THE ADJUVANT TREATM
Regulatory Filings
2020-05-29 English
Tagrisso unprecedented adjuvant lung cancer data
Regulatory Filings
2020-05-29 English
DIRECTOR/PDMR SHAREHOLDING
Regulatory Filings
2020-05-26 English
Director/PDMR Shareholding
Remuneration Information
2020-05-26 English
ENHERTU GRANTED ORPHAN DRUG DESIGNATION IN THE US FOR GASTRIC CANCER
Regulatory Filings
2020-05-22 English
Enhertu US orphan designation in gastric cancer
Regulatory Filings
2020-05-22 English
ASTRAZENECA ADVANCES RESPONSE TO GLOBAL COVID-19 CHALLENGE AS IT RECEIVES FIRST
Regulatory Filings
2020-05-21 English
AstraZeneca advances response to COVID-19 outbreak
Regulatory Filings
2020-05-21 English
LYNPARZA APPROVED IN THE US FOR HRR GENE-MUTATED METASTATIC CASTRATION-RESISTANT
Regulatory Filings
2020-05-20 English
Lynparza approved in the US for prostate cancer
Regulatory Filings
2020-05-20 English
ENHERTU US BREAKTHROUGH STATUS FOR LUNG CANCER
Regulatory Filings
2020-05-18 English
BEVESPI AEROSPHERE APPROVED IN CHINA FOR COPD
Regulatory Filings
2020-05-18 English
Enhertu US Breakthrough status for lung cancer
Regulatory Filings
2020-05-18 English
Bevespi Aerosphere approved in China for COPD
Regulatory Filings
2020-05-18 English
ENHERTU GRANTED BREAKTHROUGH THERAPY DESIGNATION IN THE US FOR HER2-POSITIVE MET
Regulatory Filings
2020-05-11 English
ASTRAZENECA RECOVERY OF GLOBAL RIGHTS TO BRAZIKUMAB (MEDI2070) FROM ALLERGAN COM
Regulatory Filings
2020-05-11 English
LYNPARZA APPROVED IN THE US AS 1ST-LINE MAINTENANCE TREATMENT WITH BEVACIZUMAB F
Regulatory Filings
2020-05-11 English
Enhertu designated gastric cancer BTD
Regulatory Filings
2020-05-11 English
Brazikumab rights recovered by AstraZeneca
Regulatory Filings
2020-05-11 English
Lynparza gets broader US ovarian cancer approval
Regulatory Filings
2020-05-11 English
FARXIGA APPROVED IN THE US FOR THE TREATMENT OF HEART FAILURE IN PATIENTS WITH H
Regulatory Filings
2020-05-06 English
Farxiga approved by FDA for heart failure (HFrEF)
Regulatory Filings
2020-05-06 English
TOTAL VOTING RIGHTS
Regulatory Filings
2020-05-01 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2020-05-01 English
RESULT OF AGM
Regulatory Filings
2020-04-29 English
Special Business Approved at AGM
AGM Information
2020-04-29 English
Result of AGM
AGM Information
2020-04-29 English
AZN: FIRST-QUARTER 2020 RESULTS
Regulatory Filings
2020-04-29 English
AZN: first-quarter 2020 results
Earnings Release Q1 2020
2020-04-29 English
LYNPARZA DEMONSTRATED OVERALL SURVIVAL BENEFIT IN PHASE III PROFOUND TRIAL FOR B
Regulatory Filings
2020-04-24 English
Lynparza shows overall survival in prostate cancer
Legal Proceedings Report
2020-04-24 English
CHANGES TO ARRANGEMENTS FOR ANNUAL GENERAL MEETING
Regulatory Filings
2020-04-17 English
Changes to arrangements for AGM
AGM Information
2020-04-17 English
KOSELUGO (SELUMETINIB) APPROVED IN US FOR PAEDIATRIC PATIENTS WITH NEUROFIBROMAT
Regulatory Filings
2020-04-14 English
TAGRISSO PHASE III ADAURA TRIAL WILL BE UNBLINDED EARLY AFTER OVERWHELMING EFFIC
Regulatory Filings
2020-04-14 English
Tagrisso adjuvant trial overwhelmingly positive
Regulatory Filings
2020-04-14 English
Koselugo (selumetinib) approved in the US for NF1
Regulatory Filings
2020-04-14 English
ASTRAZENECA DIVESTMENT OF MOVANTIK TO REDHILL BIOPHARMA COMPLETED
Regulatory Filings
2020-04-02 English
AstraZeneca divestment of Movantik completed
Regulatory Filings
2020-04-02 English
TOTAL VOTING RIGHTS
Regulatory Filings
2020-04-01 English
Total Voting Rights
Regulatory Filings
2020-04-01 English
DIRECTOR/PDMR SHAREHOLDING
Regulatory Filings
2020-03-31 English
Director/PDMR Shareholding
Director's Dealing
2020-03-31 English
FARXIGA PHASE III DAPA-CKD TRIAL WILL BE STOPPED EARLY AFTER OVERWHELMING EFFICA
Regulatory Filings
2020-03-30 English
IMFINZI APPROVED IN THE US FOR EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Regulatory Filings
2020-03-30 English
Imfinzi approved in US for small cell lung cancer
Regulatory Filings
2020-03-30 English
Farxiga CKD trial early stop for positive efficacy
Legal Proceedings Report
2020-03-30 English
DIRECTOR/PDMR SHAREHOLDING
Regulatory Filings
2020-03-26 English
LOKELMA APPROVED IN JAPAN FOR THE TREATMENT OF HYPERKALAEMIA
Regulatory Filings
2020-03-26 English
Director/PDMR Shareholding
Director's Dealing
2020-03-26 English
Lokelma approved in Japan for hyperkalaemia
Regulatory Filings
2020-03-26 English
Second Price Monitoring Extn
Regulatory Filings
2020-03-24 English
Price Monitoring Extension
Regulatory Filings
2020-03-24 English
Price Monitoring Extension
Regulatory Filings
2020-03-24 English
Second Price Monitoring Extn
Regulatory Filings
2020-03-23 English
Price Monitoring Extension
Regulatory Filings
2020-03-23 English
Second Price Monitoring Extn
Regulatory Filings
2020-03-23 English
Price Monitoring Extension
Regulatory Filings
2020-03-23 English
DIRECTOR/PDMR SHAREHOLDING
Regulatory Filings
2020-03-20 English
Second Price Monitoring Extn
Regulatory Filings
2020-03-20 English
Price Monitoring Extension
Regulatory Filings
2020-03-20 English
Director/PDMR Shareholding
Director's Dealing
2020-03-20 English
LYNPARZA GRANTED ORPHAN DRUG DESIGNATION IN JAPAN FOR BRCA-MUTATED METASTATIC PA
Regulatory Filings
2020-03-19 English
Lynparza granted orphan drug designation in Japan
Regulatory Filings
2020-03-19 English
IMFINZI CONFIRMED A SUSTAINED OVERALL SURVIVAL BENEFIT IN FINAL ANALYSIS OF THE
Regulatory Filings
2020-03-17 English
Imfinzi confirmed overall survival in CASPIAN
Earnings Release FY 2020
2020-03-17 English
Price Monitoring Extension
Regulatory Filings
2020-03-13 English
6-K
Regulatory Filings
2020-03-12 English
NOTICE OF AGM
Regulatory Filings
2020-03-12 English
Notice of AGM
AGM Information
2020-03-12 English
UPDATE ON PHASE III GY004 TRIAL FOR CEDIRANIB ADDED TO LYNPARZA IN PLATINUM-SENS
Regulatory Filings
2020-03-12 English
Update on Phase III GY004 trial for cediranib
Regulatory Filings
2020-03-12 English
Proxy Form
Proxy Solicitation & Information Statement
2020-03-12 English
AGM Notice
AGM Information
2020-03-12 English
DIRECTOR/PDMR SHAREHOLDING
Regulatory Filings
2020-03-10 English
Director/PDMR Shareholding
Director's Dealing
2020-03-10 English
UPDATE ON PHASE III DANUBE TRIAL FOR IMFINZI AND TREMELIMUMAB IN UNRESECTABLE, S
Regulatory Filings
2020-03-06 English
Update on Phase III DANUBE trial in bladder cancer
Legal Proceedings Report
2020-03-06 English
FILING OF FORM 20-F WITH SEC
Regulatory Filings
2020-03-04 English
Filing of Form 20-F with SEC
Report Publication Announcement
2020-03-04 English
IRANNOTICE
Regulatory Filings
2020-03-03 English
20-F
Annual Report FY 2019
2020-03-03 English
ANNUAL FINANCIAL REPORT
Regulatory Filings
2020-03-03 English
Annual Financial Report
Report Publication Announcement
2020-03-03 English
TOTAL VOTING RIGHTS
Regulatory Filings
2020-03-02 English
Total Voting Rights
Regulatory Filings
2020-03-02 English
ASTRAZENECA COMPLETES DIVESTMENT AGREEMENT WITH ATNAHS PHARMA FOR ESTABLISHED HY
Regulatory Filings
2020-03-02 English
Divestment of hypertension medicines completed
M&A Activity
2020-03-02 English
DIRECTOR/PDMR SHAREHOLDING
Regulatory Filings
2020-02-27 English
Director/PDMR Shareholding
Director's Dealing
2020-02-27 English
ASTRAZENECA DIVESTS GLOBAL RIGHTS TO MOVANTIK
Regulatory Filings
2020-02-25 English
AstraZeneca divests global rights to Movantik
M&A Activity
2020-02-25 English
DIRECTOR/PDMR SHAREHOLDING
Regulatory Filings
2020-02-19 English
Director/PDMR Shareholding
Director's Dealing
2020-02-19 English
AZN: FULL-YEAR AND Q4 2019 RESULTS
Regulatory Filings
2020-02-14 English
AZN: Full-year and Q4 2019 results
Earnings Release FY 2019
2020-02-14 English
4
Director's Dealing
2020-02-07 English
3
Director's Dealing
2020-02-07 English
SC 13D
Major Shareholding Notification
2020-02-07 English
Regulatory Filings 2020
Regulatory Filings
2020-02-07 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-05 English
TOTAL VOTING RIGHTS
Regulatory Filings
2020-02-03 English
Total Voting Rights
Regulatory Filings
2020-02-03 English
ZEGONA SHARE BUYBACK PROGRAMME – PROGRESS UPDATE
Transaction in Own Shares
2020-02-03 English
SC 13G
Major Shareholding Notification
2020-01-30 English
SEC SCHEDULE 13G
Major Shareholding Notification
2020-01-27 English
PHASE II DESTINY-GASTRIC01 TRIAL OF ENHERTU VERSUS CHEMOTHERAPY MET PRIMARY ENDP
Regulatory Filings
2020-01-27 English
ASTRAZENECA TO RECOVER THE GLOBAL RIGHTS TO BRAZIKUMAB (MEDI2070) FROM ALLERGAN
Regulatory Filings
2020-01-27 English
BRILINTA MET PRIMARY ENDPOINT IN PHASE III THALES TRIAL IN STROKE
Regulatory Filings
2020-01-27 English
ASTRAZENECA DIVESTS RIGHTS TO ESTABLISHED HYPERTENSION MEDICINES
Regulatory Filings
2020-01-27 English
Enhertu Phase II trial met primary endpoint
Legal Proceedings Report
2020-01-27 English
Brilinta met primary endpoint in stroke trial
Legal Proceedings Report
2020-01-27 English
AstraZeneca divests hypertension medicines
M&A Activity
2020-01-27 English
AstraZeneca to recover brazikumab (MEDI2070)
M&A Activity
2020-01-27 English
FORM F-6
Regulatory Filings
2020-01-22 English
LYNPARZA REGULATORY SUBMISSION GRANTED PRIORITY REVIEW IN THE US FOR HRR-MUTATED
Regulatory Filings
2020-01-21 English
IMFINZI AND TREMELIMUMAB GRANTED ORPHAN DRUG DESIGNATION IN THE US FOR LIVER CAN
Regulatory Filings
2020-01-21 English
FDA grants Lynparza Priority Review for PROfound
Regulatory Filings
2020-01-20 English
Imfinzi, tremelimumab granted ODD in liver cancer
Regulatory Filings
2020-01-20 English
LYNPARZA REGULATORY SUBMISSION GRANTED PRIORITY REVIEW IN THE US FOR 1ST-LINE MA
Regulatory Filings
2020-01-13 English
UPDATE ON PHASE III STRENGTH TRIAL FOR EPANOVA IN MIXED DYSLIPIDAEMIA
Regulatory Filings
2020-01-13 English
Lynparza granted FDA Priority Review for PAOLA-1
Regulatory Filings
2020-01-13 English
Update on Epanova Phase III STRENGTH trial
Legal Proceedings Report
2020-01-13 English
LOKELMA APPROVED IN CHINA FOR THE TREATMENT OF ADULT PATIENTS WITH HYPERKALAEMIA
Regulatory Filings
2020-01-06 English
FARXIGA GRANTED FDA PRIORITY REVIEW FOR PATIENTS WITH HEART FAILURE WITH REDUCED
Regulatory Filings
2020-01-06 English
Farxiga granted FDA heart failure Priority Review
Regulatory Filings
2020-01-06 English
Lokelma approved in China for hyperkalaemia
Regulatory Filings
2020-01-06 English
TOTAL VOTING RIGHTS
Regulatory Filings
2020-01-02 English
Total Voting Rights
Regulatory Filings
2020-01-02 English